Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 98  Show
  1. 1
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules."
    Schmucker B., Tang Y., Kressel M.
    Hum. Mol. Genet. 8:1561-1570(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 7; 9 AND 10), SUBCELLULAR LOCATION.
    Category: Subcellular Location, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    "Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts."
    Chang L.-S., Akhmametyeva E.M., Wu Y., Zhu L., Welling D.B.
    Genomics 79:63-76(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3; 4; 5; 6 AND 8).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  6. 6
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 265 other entries.

  7. 7
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
    Category: Sequences.
    Tissue: Lung and Skin.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50448 other entries.

  8. 8
    "The gene of neurofibromatosis type 2."
    Marineau C., Merel P., Rouleau G.A., Thomas G.
    Medecine/Sciences 11:35-42(1995)
    Cited for: REVIEW.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins."
    Murthy A., Gonzalez-Agosti C., Cordero E., Pinney D., Candia C., Solomon F., Gusella J., Ramesh V.
    J. Biol. Chem. 273:1273-1276(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH SLC9A3R1.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 1 other entries.

  10. 10
    "The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate."
    Scoles D.R., Huynh D.P., Chen M.S., Burke S.P., Gutmann D.H., Pulst S.-M.
    Hum. Mol. Genet. 9:1567-1574(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HGS.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  11. 11
    "Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins."
    Goutebroze L., Brault E., Muchardt C., Camonis J., Thomas G.
    Mol. Cell. Biol. 20:1699-1712(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH SCHIP1, CHARACTERIZATION OF VARIANTS NF2 PHE-119 DEL, CHARACTERIZATION OF VARIANT MET-219.
    Category: Pathology & Biotech, Interaction, Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 2 other entries.

  12. 12
    Cited for: INVOLVEMENT IN MESOM.
    Category: Pathology & Biotech.
    Source: UniProtKB/Swiss-Prot (reviewed).
  13. 13
    Cited for: INTERACTION WITH SGSM3.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 5 other entries.

  14. 14
    "Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L."
    Rong R., Tang X., Gutmann D.H., Ye K.
    Proc. Natl. Acad. Sci. U.S.A. 101:18200-18205(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH AGAP2, MUTAGENESIS OF LEU-64.
    Category: Pathology & Biotech, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  15. 15
    "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
    Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
    Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3176 other entries.

  16. 16
    "VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation."
    Huang J., Chen J.
    Oncogene 27:4056-4064(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH DCAF1, UBIQUITINATION.
    Category: PTM / Processing, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 17 other entries.

  17. 17
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 8770 other entries.

  18. 18
    "Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin."
    Seo P.-S., Quinn B.J., Khan A.A., Zeng L., Takoudis C.G., Hanada T., Bolis A., Bolino A., Chishti A.H.
    Exp. Biol. Med. 234:255-262(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH MPP1, SUBCELLULAR LOCATION.
    Category: Subcellular Location, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 1 other entries.

  19. 19
    "Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus."
    Li W., You L., Cooper J., Schiavon G., Pepe-Caprio A., Zhou L., Ishii R., Giovannini M., Hanemann C.O., Long S.B., Erdjument-Bromage H., Zhou P., Tempst P., Giancotti F.G.
    Cell 140:477-490(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DCAF1 AND THE CUL4A-RBX1-DDB1-VPRBP/DCAF1 E3 UBIQUITIN-PROTEIN LIGASE COMPLEX, PHOSPHORYLATION, MUTAGENESIS OF LEU-64 AND SER-518, CHARACTERIZATION OF VARIANT ARG-46, CHARACTERIZATION OF VARIANTS NF2 SER-62 AND PRO-141.
    Category: Function, Subcellular Location, Pathology & Biotech, PTM / Processing, Interaction, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  20. 20
    "Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded."
    Yu J., Zheng Y., Dong J., Klusza S., Deng W.-M., Pan D.
    Dev. Cell 18:288-299(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION.
    Category: Function.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 6 and mapped to 35 other entries.

  21. 21
    "Kibra Is a regulator of the Salvador/Warts/Hippo signaling network."
    Genevet A., Wehr M.C., Brain R., Thompson B.J., Tapon N.
    Dev. Cell 18:300-308(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH WWC1.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 34 other entries.

  22. 22
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 18117 other entries.

  23. 23
    "Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus."
    Chen H., Mei L., Zhou L., Zhang X., Guo C., Li J., Wang H., Zhu Y., Zheng Y., Huang L.
    Int. J. Biochem. Cell Biol. 43:545-555(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH NOP53, PHOSPHORYLATION.
    Category: Function, PTM / Processing, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 7 other entries.

  24. 24
    "Toward a comprehensive characterization of a human cancer cell phosphoproteome."
    Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., Mohammed S.
    J. Proteome Res. 12:260-271(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 13412 other entries.

  25. 25
    "The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product."
    Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S.
    Acta Crystallogr. D 58:381-391(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-313.
    Category: Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
1 to 25 of 98  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again